PABESORAG TAB. 150 MG./12.5 MG. CAJA C/28 (IRBESARTAN-HIDROCLOTIAZIDA) PATENTE FORMA FARMACÉUTICA: 3 TABLETAS

Description

FORMA FARMACÉUTICA: 3 TABLETAS

PRESENTACIÓN: 1 CAJA

PRINCIPIO ACTIVO: LEVODROPROPICINA

Cada tableta contiene 5 mg de empagliflozina y 850 mg de metformina

PABESORAG TAB. 150 MG./12.5 MG. CAJA C/28 (IRBESARTAN-HIDROCLOTIAZIDA) PATENTE FORMA FARMACÉUTICA: 3 TABLETAS

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy